State Of Alaska, Department Of Revenue Collegium Pharmaceutical, Inc Transaction History
State Of Alaska, Department Of Revenue
- $8.91 Billion
- Q2 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 19,208 shares of COLL stock, worth $722,604. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,208
Previous 19,867
3.32%
Holding current value
$722,604
Previous $771,000
19.84%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding COLL
# of Institutions
236Shares Held
39.4MCall Options Held
84.2KPut Options Held
18.6K-
Black Rock Inc. New York, NY5.79MShares$218 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$128 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$99.1 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$89.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$87.8 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.28B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...